These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues]. Klepper LIa. Med Tekh; 2000; (4):37-41. PubMed ID: 10984881 [Abstract] [Full Text] [Related]
5. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1258-67. PubMed ID: 15001271 [Abstract] [Full Text] [Related]
6. [The interactive determination of the mathematical model parameters for the planning of the radiation therapy of malignant tumors. 2. A method of adjusting the mathematical model parameters for calculating the tolerance doses and probabilities of the occurrence of radiation complications in body organs and tissues]. Klepper LIa. Med Tekh; 2000 Mar 15; (5):36-40. PubMed ID: 11076364 [Abstract] [Full Text] [Related]
7. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):683-9. PubMed ID: 15927412 [Abstract] [Full Text] [Related]
8. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1268-79. PubMed ID: 15001272 [Abstract] [Full Text] [Related]
9. [Method of calculating the equivalent tumor dose as a function as to irradiated tumor tissue volume]. Klepper LIa. Med Tekh; 2001 Mar 15; (4):15-20. PubMed ID: 11534286 [Abstract] [Full Text] [Related]
10. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Rancati T, Wennberg B, Lind P, Svane G, Gagliardi G. Radiother Oncol; 2007 Mar 15; 82(3):308-16. PubMed ID: 17224197 [Abstract] [Full Text] [Related]
12. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Daşu A, Toma-Daşu I, Olofsson J, Karlsson M. Acta Oncol; 2005 Mar 15; 44(4):339-47. PubMed ID: 16120542 [Abstract] [Full Text] [Related]
13. [Assessment of tolerance doses in multifractionated irradiation of the lung using Ellis and LQ models]. Il'in VI, Klepper LIa. Med Tekh; 1998 Mar 15; (1):34-7. PubMed ID: 9560817 [Abstract] [Full Text] [Related]
18. Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms. Takeda A, Shigematsu N, Ikeda T, Kawaguchi O, Kutsuki S, Ishibashi R, Kunieda E, Takeda T, Takemasa K, Ito H, Uno T, Jinno H, Kubo A. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1280-8. PubMed ID: 15001273 [Abstract] [Full Text] [Related]
19. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):847-52. PubMed ID: 18262098 [Abstract] [Full Text] [Related]